DiaSorin S.p.A. | |
Stock Exchange | Electronic Share Market |
EPS |
EUR2.78 |
Market Cap |
EUR4.95 B |
Shares Outstanding |
55.95 M |
Public Float |
14.36 M |
DiaSorin S.p.A. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
23.7 M |
Public Float |
- |
Address |
Via Crescentino snc Saluggia Vercelli 13040 Italy |
Employees | - |
Website | http://www.diasorin.com |
Updated | 07/08/2019 |
DiaSorin SpA engages in the development, production, and marketing of reagent kits for in vitro diagnostics. It specializes in the provision of immunodiagnostics and molecular diagnostics solutions which meet the needs of the following clinical areas: infectious diseases, cardiac markers, bone metabolism, hepatitis and retrovirus, oncology and endocrinology. The company was founded in 1968 and is headquartered in Vercelli, Italy . |